Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04371367 |
|---|---|
| Brief Title: | Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) (FORCE) |
| First Submitted : | April 29, 2020 |
| First Submitted that Met QC Criteria : | April 30, 2020 |
| First Posted : | May 1, 2020 |
| Last Update Submitted that Met QC Criteria : | January 11, 2021 |
| Last Update Posted : | January 12, 2021 |